MedPath

Variability of quantitative Ga68-PSMA PET: a test-retest pilot study

Completed
Conditions
Prostate cancer with biochemical relapse
recurrent prostate cancer
10038597
Registration Number
NL-OMON43731
Lead Sponsor
Catharina-ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Biochemical recurrence of prostate cancer and
eligible for PSMA PET for restaging and
at least one visually PSMA positive tumour site and
mentally competent

Exclusion Criteria

Age < 18 years
Mentally incompetent
Currently on hormone, chemo, radiation or radionuclide treatment

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath